NO20085063L - Analyse for lantanhydroksykarbon - Google Patents

Analyse for lantanhydroksykarbon

Info

Publication number
NO20085063L
NO20085063L NO20085063A NO20085063A NO20085063L NO 20085063 L NO20085063 L NO 20085063L NO 20085063 A NO20085063 A NO 20085063A NO 20085063 A NO20085063 A NO 20085063A NO 20085063 L NO20085063 L NO 20085063L
Authority
NO
Norway
Prior art keywords
hydroxycarbon
lanthanum
analysis
impurity
analyzing
Prior art date
Application number
NO20085063A
Other languages
English (en)
Inventor
Donald Hallenbeck
Simon Bates
Original Assignee
Shire Internat Licensing Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Internat Licensing Bv filed Critical Shire Internat Licensing Bv
Publication of NO20085063L publication Critical patent/NO20085063L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F17/00—Compounds of rare earth metals
    • C01F17/20—Compounds containing only rare earth metals as the metal element
    • C01F17/247—Carbonates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • G01N23/207—Diffractometry using detectors, e.g. using a probe in a central position and one or more displaceable detectors in circumferential positions
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Geology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

Det beskrives en analysemetode for analyttisk bestemmelse av mengden av en urenhet i en fast prøve. Denne røntgen diffraksjonsmetoden benytter fortrinnsvis Rietveld raffinering.
NO20085063A 2006-05-05 2008-12-04 Analyse for lantanhydroksykarbon NO20085063L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/418,666 US20070259052A1 (en) 2006-05-05 2006-05-05 Assay for lanthanum hydroxycarbonate
PCT/US2007/061461 WO2007130721A2 (en) 2006-05-05 2007-02-01 Assay for lanthanum hydroxycarbonate

Publications (1)

Publication Number Publication Date
NO20085063L true NO20085063L (no) 2008-12-04

Family

ID=38661464

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085063A NO20085063L (no) 2006-05-05 2008-12-04 Analyse for lantanhydroksykarbon

Country Status (15)

Country Link
US (3) US20070259052A1 (no)
JP (1) JP2009536356A (no)
KR (1) KR20090016465A (no)
CN (1) CN101484798A (no)
AU (1) AU2007248374A1 (no)
BR (1) BRPI0710343A2 (no)
CA (1) CA2651344A1 (no)
EA (1) EA200802169A1 (no)
IL (1) IL195051A0 (no)
MA (1) MA31601B1 (no)
MX (1) MX2008014148A (no)
NO (1) NO20085063L (no)
SG (1) SG171656A1 (no)
TW (1) TW200742849A (no)
WO (1) WO2007130721A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060083791A1 (en) * 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
WO2006044657A2 (en) * 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden
WO2010106557A2 (en) * 2009-03-20 2010-09-23 Panacea Biotec Limited Stable pharmaceutical formulations comprising anhydrous lanthanum carbonate and process for preparation thereof
BRPI0924533A2 (pt) * 2009-05-15 2015-06-30 Natco Pharma Ltd Processo para a preparação de carbonato de latânio di-hidratado
KR101940207B1 (ko) * 2010-05-12 2019-01-18 스펙트럼 파마슈티컬즈 인크 란탄 카보네이트 하이드록사이드, 란탄 옥시카보네이트 및 이들의 제조 및 사용 방법
US8697132B2 (en) 2010-12-01 2014-04-15 Shire Llc Capsule and powder formulations containing lanthanum compounds
US8263119B2 (en) 2010-12-01 2012-09-11 Shire Llc Capsule formulations containing lanthanum compounds
US9513237B2 (en) * 2011-05-17 2016-12-06 Zetacube S.R.L. Method of detecting polymorphs using synchrotron radiation
ES2671622T3 (es) 2011-12-21 2018-06-07 Iso Therapeutics Group Llc Composiciones y métodos radiactivos para su uso terapéutico
WO2013184373A1 (en) 2012-06-05 2013-12-12 3M Innovative Properties Company Lanthanum-based concentration agents for microorganisms
CN102671684B (zh) * 2012-06-06 2013-10-30 福州大学 一种复合光催化剂及其制备方法和应用
CN103604820A (zh) * 2013-11-27 2014-02-26 南京钢铁股份有限公司 一种提高xrd实验精度的方法
JP5968401B2 (ja) * 2014-11-12 2016-08-10 三菱重工業株式会社 高温部材の温度推定方法、準安定正方相の含有量測定方法、劣化判定方法
CN110579499A (zh) * 2018-06-08 2019-12-17 北京华睿鼎信科技有限公司 一种碳酸镧或其制剂中碱式碳酸镧杂质的检定方法
CN110095489A (zh) * 2019-05-22 2019-08-06 北京悦康科创医药科技股份有限公司 一种碳酸镧咀嚼片中杂质碱式碳酸镧的定量测定方法
CN111620363A (zh) * 2020-06-13 2020-09-04 南京卡文迪许生物工程技术有限公司 一种四水合碳酸镧的制备方法及其产品
CN113019305B (zh) * 2021-03-03 2021-10-15 重庆三峡学院 多孔碱式碳酸镧磷酸盐吸附剂的制备及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246246A (en) 1977-12-10 1981-01-20 Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry Method for manufacture of hydrated borates
US4592082A (en) * 1984-08-10 1986-05-27 The United States Of America As Represented By The United States Department Of Energy Quantitative determination of mineral composition by powder X-ray diffraction
JPH06705B2 (ja) 1985-12-19 1994-01-05 旭化成工業株式会社 リン酸イオンの固定化剤
US5045289A (en) 1989-10-04 1991-09-03 Research Corporation Technologies, Inc. Formation of rare earth carbonates using supercritical carbon dioxide
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
JPH06171950A (ja) 1992-12-02 1994-06-21 Shin Etsu Chem Co Ltd ランタンマンガナイト粉末の製造方法
US5562921A (en) * 1994-07-15 1996-10-08 Sherman; Bernard C. Stable solid pharmaceutical compositions containing enalapril maleate
US5435986A (en) * 1994-08-30 1995-07-25 Industrial Technology Research Institute Method for preparing high purity aluminum hydroxide
GB9506126D0 (en) 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
US6281503B1 (en) * 1998-05-06 2001-08-28 Quanta Vision, Inc. Non-invasive composition analysis
US20010014352A1 (en) * 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
US6055293A (en) * 1998-06-30 2000-04-25 Seh America, Inc. Method for identifying desired features in a crystal
CN1122702C (zh) 1998-12-29 2003-10-01 中国石油化工集团公司 一种烃类催化裂化硫转移助剂及其使用方法
AUPQ109499A0 (en) 1999-06-21 1999-07-15 Adelaide Brighton Management Limited Sample presentation for x-ray diffraction
US6160016A (en) * 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder
GB0015745D0 (en) 2000-06-27 2000-08-16 Shire Holdings Ag Treatment of bone diseases
EP1321142A1 (en) 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
US7469036B2 (en) * 2002-04-19 2008-12-23 Los Alamos National Security, Llc Analysis of macromolecules, ligands and macromolecule-ligand complexes
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20040161474A1 (en) 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US6678347B1 (en) 2002-07-26 2004-01-13 Hypernex, Inc. Method and apparatus for quantitative phase analysis of textured polycrystalline materials
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
US7256049B2 (en) 2003-09-04 2007-08-14 Tandem Labs Devices and methods for separating phospholipids from biological samples
DE10346433B4 (de) 2003-10-07 2006-05-11 Bruker Axs Gmbh Analytisches Verfahren zum Bestimmen von kristallographischen Phasen einer Messprobe
NZ552861A (en) * 2004-07-27 2010-11-26 Shire Pharmaceuticals Inc Method of treating hyperphosphataemia using lanthanum hydroxycarbonate
WO2006044657A2 (en) 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden

Also Published As

Publication number Publication date
MX2008014148A (es) 2009-01-27
US20080089948A1 (en) 2008-04-17
IL195051A0 (en) 2009-08-03
CN101484798A (zh) 2009-07-15
EA200802169A1 (ru) 2009-06-30
WO2007130721A2 (en) 2007-11-15
CA2651344A1 (en) 2007-11-15
AU2007248374A1 (en) 2007-11-15
AU2007248374A2 (en) 2008-11-27
KR20090016465A (ko) 2009-02-13
US7618656B2 (en) 2009-11-17
BRPI0710343A2 (pt) 2011-08-09
US20070259052A1 (en) 2007-11-08
TW200742849A (en) 2007-11-16
US20100092576A1 (en) 2010-04-15
MA31601B1 (fr) 2010-08-02
JP2009536356A (ja) 2009-10-08
WO2007130721A3 (en) 2008-04-10
SG171656A1 (en) 2011-06-29

Similar Documents

Publication Publication Date Title
NO20085063L (no) Analyse for lantanhydroksykarbon
WO2008039946A3 (en) Integrated meter for analyzing biological samples
ATE538715T1 (de) System zur in vivo analyse
MY145833A (en) Micro-hydrocarbon analysis
WO2010099108A3 (en) Multiplexing derivatized anayltes using mass spectroscopy
WO2009134944A3 (en) Methods of determining the health status of an individual
WO2010070133A3 (en) A cytological method for analyzing a consolidated biological sample by raman spectroscopy
IN2014DN02241A (no)
WO2009051821A3 (en) Sample preparation devices and analyzers
EP4249605A3 (en) Methods for analyte detection
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
MX2009006600A (es) Analizador de muestras.
MX2010004091A (es) Metodo de analisis de inmunoensayo.
WO2009075764A3 (en) Methods and apparatus for analyzing samples and collecting sample fractions
WO2007002579A3 (en) Assay cartridges and methods for point of care instruments
EP1962085A3 (en) Apparatus for emitting and detecting beams of light
EP1873533A4 (en) TEST CHIP FOR SAMPLE ANALYSIS AND MICRO ANALYSIS SYSTEM
EP1891433A4 (en) METHOD FOR CLASSIFYING CHEMICALLY CROSS-LINKED CELLULAR SAMPLES BY MASS SPECTRUM
WO2006124100A3 (en) Method for quantitative analysis of mixtures of compounds
WO2009137138A3 (en) Methods of analyzing samples for bacteria using whole cell capture and atp analysis
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2009073505A3 (en) Methods for processing tandem mass spectral data for protein sequence analysis
WO2008048508A3 (en) Prognostic biomarkers in patients with ovarian cancer
WO2008151207A3 (en) Expression quantification using mass spectrometry
RU2011140471A (ru) Способ диагностики эндометриоза и диагностический набор для эндометриоза

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application